+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epogen"

Darbepoetin Alfa (Aranesp) Global Market Report 2024 - Product Thumbnail Image

Darbepoetin Alfa (Aranesp) Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Epoetin alfa- Biosimilar Insight, 2022 - Product Thumbnail Image

Epoetin alfa- Biosimilar Insight, 2022

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Drug Overview: Epogen - Product Thumbnail Image

Drug Overview: Epogen

  • Drug Pipelines
  • January 2018
  • 27 Pages
  • Global
From
Drug Overview: NeoRecormon - Product Thumbnail Image

Drug Overview: NeoRecormon

  • Drug Pipelines
  • January 2018
  • 8 Pages
  • Global
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Epogen is a brand of hematological drug used to treat anemia caused by chronic kidney disease. It is a recombinant form of erythropoietin, a hormone produced by the kidneys that stimulates the production of red blood cells. Epogen is administered by injection or intravenous infusion and is used to increase the number of red blood cells in the body. It is also used to reduce the need for blood transfusions in patients with anemia due to chemotherapy or HIV infection. Epogen is a widely used drug in the hematological market, and is often prescribed in combination with other drugs to treat anemia. It is also used to treat anemia in patients with cancer, HIV, and other conditions. The drug is available in both generic and brand-name forms. Companies in the Epogen market include Amgen, Johnson & Johnson, Pfizer, and Novartis. Show Less Read more